NASDAQ:ASTH Astrana Health (ASTH) Stock Price, News & Analysis $30.02 +0.16 (+0.54%) Closing price 04/2/2025 04:00 PM EasternExtended Trading$31.74 +1.72 (+5.74%) As of 07:00 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About Astrana Health Stock (NASDAQ:ASTH) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Astrana Health alerts:Sign Up Key Stats Today's Range$29.31▼$30.4550-Day Range$25.38▼$39.2052-Week Range$23.12▼$63.20Volume285,757 shsAverage Volume262,927 shsMarket Capitalization$1.50 billionP/E Ratio23.09Dividend YieldN/APrice Target$53.29Consensus RatingModerate Buy Company OverviewAstrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.Read More… Remove Ads Astrana Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks76th Percentile Overall ScoreASTH MarketRank™: Astrana Health scored higher than 76% of companies evaluated by MarketBeat, and ranked 189th out of 927 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.4 / 5Analyst RatingModerate Buy Consensus RatingAstrana Health has received a consensus rating of Moderate Buy. The company's average rating score is 2.80, and is based on 6 buy ratings, 3 hold ratings, and no sell ratings.Amount of Analyst CoverageAstrana Health has been the subject of 5 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Astrana Health's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth22.61% Earnings GrowthEarnings for Astrana Health are expected to grow by 22.61% in the coming year, from $1.15 to $1.41 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Astrana Health is 23.09, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 22.49.Price to Earnings Ratio vs. SectorThe P/E ratio of Astrana Health is 23.09, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 23.09.Price to Earnings Growth RatioAstrana Health has a PEG Ratio of 1.37. PEG Ratios above 1 indicate that a company could be overvalued.Price to Book Value per Share RatioAstrana Health has a P/B Ratio of 2.84. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Astrana Health's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted3.97% of the float of Astrana Health has been sold short.Short Interest Ratio / Days to CoverAstrana Health has a short interest ratio ("days to cover") of 4.1.Change versus previous monthShort interest in Astrana Health has recently increased by 2.78%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldAstrana Health does not currently pay a dividend.Dividend GrowthAstrana Health does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted3.97% of the float of Astrana Health has been sold short.Short Interest Ratio / Days to CoverAstrana Health has a short interest ratio ("days to cover") of 4.1.Change versus previous monthShort interest in Astrana Health has recently increased by 2.78%, indicating that investor sentiment is decreasing. News and Social Media3.7 / 5News Sentiment0.69 News SentimentAstrana Health has a news sentiment score of 0.69. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.53 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 10 news articles for Astrana Health this week, compared to 4 articles on an average week.Search Interest10 people have searched for ASTH on MarketBeat in the last 30 days. This is an increase of 43% compared to the previous 30 days.MarketBeat Follows1 people have added Astrana Health to their MarketBeat watchlist in the last 30 days. Company Ownership0.8 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Astrana Health insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 8.46% of the stock of Astrana Health is held by insiders.Percentage Held by Institutions52.77% of the stock of Astrana Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Astrana Health's insider trading history. Receive ASTH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Astrana Health and its competitors with MarketBeat's FREE daily newsletter. Email Address ASTH Stock News HeadlinesBarclays Initiates Coverage on Astrana Health (NASDAQ:ASTH)April 3 at 1:55 AM | americanbankingnews.comAstrana Health initiated with an Equal Weight at BarclaysApril 2 at 7:49 AM | markets.businessinsider.comTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth, your savings, and your retirement. When the dollar collapses, your savings could disappear overnight. With Trump threatening Russia with more sanctions, Russia is rushing to finalize their BRICS payment system aimed to destroy the U.S dollar.April 3, 2025 | Priority Gold (Ad)Astrana Health (ASTH) Has a New Rating from BarclaysApril 2 at 7:49 AM | markets.businessinsider.com1ASTH : Assessing Astrana Health: Insights From 6 Financial AnalystsApril 2 at 7:49 AM | benzinga.comBarclays Initiates Coverage of Astrana Health (ASTH) with Equal-Weight RecommendationApril 2 at 7:49 AM | msn.comAstrana Health, Inc. (NASDAQ:ASTH) Receives $56.17 Average Target Price from AnalystsMarch 30, 2025 | americanbankingnews.comAstrana Health (ASTH) Gets a Buy from Lake StreetMarch 24, 2025 | markets.businessinsider.comSee More Headlines ASTH Stock Analysis - Frequently Asked Questions How have ASTH shares performed this year? Astrana Health's stock was trading at $31.53 at the start of the year. Since then, ASTH shares have decreased by 4.8% and is now trading at $30.02. View the best growth stocks for 2025 here. How were Astrana Health's earnings last quarter? Astrana Health, Inc. (NASDAQ:ASTH) announced its quarterly earnings results on Thursday, February, 27th. The company reported ($0.15) EPS for the quarter, missing the consensus estimate of $0.22 by $0.37. The firm earned $665.21 million during the quarter, compared to analyst estimates of $617.24 million. Astrana Health had a net margin of 3.63% and a trailing twelve-month return on equity of 9.37%. How do I buy shares of Astrana Health? Shares of ASTH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Astrana Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Astrana Health investors own include Tesla (TSLA), JPMorgan Chase & Co. (JPM), NVIDIA (NVDA), Advanced Micro Devices (AMD), Meta Platforms (META), Netflix (NFLX) and Visa (V). Company Calendar Last Earnings2/27/2025Today4/03/2025Next Earnings (Estimated)5/06/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Management consulting services Sub-IndustryBusiness Services Current SymbolNASDAQ:ASTH Previous SymbolNASDAQ:ASTH CIK1083446 Webwww.apollomed.net Phone626-282-0288Fax818-839-5190Employees1,800Year FoundedN/APrice Target and Rating Average Stock Price Target$53.29 High Stock Price Target$70.00 Low Stock Price Target$36.00 Potential Upside/Downside+77.5%Consensus RatingModerate Buy Rating Score (0-4)2.80 Research Coverage10 Analysts Profitability EPS (Most Recent Fiscal Year)$0.89 Trailing P/E Ratio23.09 Forward P/E Ratio26.10 P/E Growth1.37Net Income$60.72 million Net Margins3.63% Pretax Margin4.86% Return on Equity9.37% Return on Assets5.32% Debt Debt-to-Equity Ratio0.60 Current Ratio1.91 Quick Ratio1.91 Sales & Book Value Annual Sales$2.03 billion Price / Sales0.74 Cash Flow$1.15 per share Price / Cash Flow26.15 Book Value$10.58 per share Price / Book2.84Miscellaneous Outstanding Shares50,120,000Free Float51,494,000Market Cap$1.50 billion OptionableOptionable Beta1.30 A Beginner's Guide to Investing in CannabisUnlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.Get This Free Report This page (NASDAQ:ASTH) was last updated on 4/3/2025 by MarketBeat.com Staff From Our PartnersBITCOINDid you miss out on the 1000%+ gains of Bitcoin over the past 5 years? If so, you don't want to miss this.....Awesomely, LLC | SponsoredTrump Allies Confirm Exec Order 14024 Triggers Dollar CollapseExecutive Order 14024 is paving the way for irreversible damage to the dollar's value—threatening your wealth,...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredA market crash is coming—here’s whenThe stock market cycle I've used to identify the most likely day of the next market crash is the exact same in...Chaikin Analytics | SponsoredDOGE Social Security bombshell?Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Astrana Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Astrana Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.